Aspen Neuroscience, Inc. (ASPE) SEC filings
ASPENasdaqPharmaceutical PreparationsFiscal year ends December 31
$12.00−0.23 (-1.88%)
Close on Nov 17, 2026Market cap –P/E –Yield –
SEC filings
1 of Aspen Neuroscience's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Nov 2, 2026 | Nov 2, 2026 | SEC EDGAR |
See a number that looks wrong?